T lymphoblastic leukemia/lymphoma
Clinical trials for T lymphoblastic leukemia/lymphoma explained in plain language.
Never miss a new study
Get alerted when new T lymphoblastic leukemia/lymphoma trials appear
Sign up with your email to follow new studies for T lymphoblastic leukemia/lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New maintenance therapy shows promise in preventing T-Cell cancer relapse after transplant
Disease control CompletedThis study tested whether a low dose of the drug chidamide, given after a donor stem cell transplant, can help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. Forty-four patients aged 14 to 70 who were at high risk of relapse took part. The main g…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Experimental combo aims to boost stem cell transplant for rare blood cancers
Disease control CompletedThis early-phase trial tested whether adding the drug romidepsin before and after a stem cell transplant could help control T-cell cancers like lymphoma and leukemia. Twenty-three patients received romidepsin along with standard chemotherapy, followed by a donor stem cell transpl…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase 1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:59 UTC